OphthaliX Withdrawn, NYSE: OPH.RC

Clinical-stage biotech developing treatments for ophthalmic disorders.

Industry: Other

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Other

Clinical-stage biotech developing treatments for ophthalmic disorders.
more less
IPO News for OphthaliX
more
IPO Data
IPO File Date 07/02/2013
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $10
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $10
Underwriters
more
Company Data
Headquarters Petach Tikva, Israel
Founded 1999
Employees 1
Website www.ophthalix.com